What is Proton Therapy
Read our Covid-19 policy

Call Now For More Information

General Questions or
Schedule an Appointment


Current Patients


Physician Line


Read our Covid-19 policy

Recap of our Involvement at the Particle Therapy Conference

Recap of our Involvement at the Particle Therapy Conference

Last month a group of staff and doctors from SCCA Proton Therapy Center attended the 58th Annual Conference of the Particle Therapy Co-Operative Group, PTCOG58, in Manchester, England. PTCOG exists to promote science, technology, and practical clinical application of particle therapy, with the ultimate goal of improving treatment of cancer to the highest possible standards in radiation therapy.

Each year, PTCOG showcases cutting-edge science and clinical practice in action. The event brings together speakers, influencers and medical experts in the field from across the world to share the latest research, and technological and clinical innovation in particle therapy through educational sessions and scientific programs. Associate Medical Director Dr. Jing Zeng, one of the SPTC doctors presenting at the meeting said, "I enjoy hearing ideas from different groups about similar projects they are also working on, and from different perspectives that add to the impact of our work."

Our SCCA Proton Therapy Center experts shared their latest academic findings in a series of papers, posters, and presentations. Their work showcased some of the most recent data from proton therapy studies and highlighted some of the latest technological advancements. SCCA Proton Therapy Center Medical Director Dr. Ramesh Rengan and Dr. Zeng both presented findings on lung cancer and proton therapy, while Dr. Jim Apisarnthanarax presented a poster with fellow researchers on toxicity risk prediction in primary liver cancer using proton therapy. Other presenters from SPTC included vice president of operations, Jason Dixon, and former SCCA Proton Therapy Center Fellow, Saif Aljabab, who presented a paper about neutron and proton radiotherapy for locally advanced salivary gland tumors. Additionally, several interdisciplinary teams from SPTC and UW Medicine were on hand to present their findings on subjects including ocular cancer, nasopharyngeal cancer, and more.

Dr. Zeng's work was well-received by attendees. "It was exciting to see a lot of clinical data in general working to provide real-life comparisons between proton radiation and photon radiation; that remains an unanswered question for many cancers, but the answers are starting to be filled in," said Dr. Zeng. "Most proton centers agree that for stage III lung cancer, proton therapy can provide better dosimetry than photon radiation, and we are all trying to figure out how to show that this leads to improved clinical outcomes."

Tony Wong, Angela Fung and other members of the Proton Center's physics department attended the conference as well. The pair enjoyed engaging in discussions with some other centers interested in their work on multi-field optimization (MFO) vs. single field optimization (SFO) for head and neck treatments, as well as learning from other presenters and networking with peers. When asked what they enjoyed most about the conference, they told us they enjoyed learning about the latest developments and research in FLASH Therapy because "It's fresh, and it's potentially a complete paradigm shift in radiation therapy."

We're proud of the work of our team from SPTC and excited that their work is making an impact in the world. Keep up the excellent work!